Biofrontera Ag Company Profile (LON:B8F)

About Biofrontera Ag

Biofrontera Ag logo

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: B8F
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $141.22
  • 200 Day Moving Average: $163.20
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for Biofrontera Ag (LON:B8F) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Biofrontera Ag (LON:B8F)
Show:
DateFirmActionRatingPrice TargetDetails
2/17/2016Shore CapitalReiterated Ratinghouse stockView Rating Details
4/10/2015FinnCapReiterated RatingUnder ReviewView Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Biofrontera Ag (LON:B8F)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Biofrontera Ag (LON:B8F)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Biofrontera Ag (LON:B8F)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Biofrontera Ag (LON:B8F)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Biofrontera Ag (LON:B8F)
DateHeadline
4-traders.com logoBiofrontera : Receives Label Expansion for Ameluz® in Europe to Include Field Cancerization (LON:B8F)
www.4-traders.com - September 17 at 8:33 AM
News IconBiofrontera AG: Biofrontera Receives Label Expansion for Ameluz® in Europe to Include Field Cancerization (LON:B8F)
www.pressetext.com - September 17 at 8:33 AM
News IconBiofrontera AG: Biofrontera Reports Financial Results and Business Update for Second Quarter and First Half 2016 (LON:B8F)
www.pressetext.com - August 31 at 3:41 PM
News IconPTA-News: Biofrontera AG: Biofrontera Reports Financial Results and Business Update for Second Quarter and First Half 2016 (LON:B8F)
www.onvista.de - August 31 at 8:33 AM
News IconBiofrontera AG: Biofrontera to Present at the 18th Annual Rodman & Renshaw Global Investment Conference (LON:B8F)
www.pressetext.com - August 30 at 9:34 AM
4-traders.com logoBiofrontera : präsentiert auf der 18. Rodman & Renshaw Global Investment Konferenz (LON:B8F)
www.4-traders.com - August 30 at 9:34 AM
News IconBiofrontera AG: Biofrontera Accelerates Production of BF-RhodoLED® Lamps to Prepare for U.S. Commercial Launch (LON:B8F)
www.pressetext.com - August 26 at 3:40 PM
News IconPTA-News: Biofrontera AG: Biofrontera Accelerates Production of BF-RhodoLED® Lamps to Prepare for U.S. Commercial Launch (LON:B8F)
www.onvista.de - August 26 at 3:40 PM
4-traders.com logoBiofrontera : Notice of half-year report of 2016 (LON:B8F)
www.4-traders.com - August 25 at 3:45 PM
News IconPTA-News: Biofrontera AG: Notice of half-year report of 2016 (LON:B8F)
www.onvista.de - August 25 at 3:45 PM
News IconBiofrontera AG: Notice of half-year report of 2016 (LON:B8F)
www.pressetext.com - August 25 at 3:45 PM
live-pr.com logoBiofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review - New Report Available (LON:B8F)
www.live-pr.com - August 4 at 3:49 PM
4-traders.com logoBiofrontera : Receives Favourable CHMP Assessment for Field-Directed Therapy and Files BCC Application (LON:B8F)
www.4-traders.com - July 28 at 12:28 PM
News IconBiofrontera AG: Biofrontera Receives Favourable CHMP Assessment for Field-Directed Therapy and Files BCC Application (LON:B8F)
www.pressetext.com - July 28 at 12:28 PM
News IconPTA-News: Biofrontera AG: Biofrontera to Present at the Canaccord Genuity Annual Growth Conference (LON:B8F)
www.onvista.de - July 25 at 8:31 AM
News IconBiofrontera AG: Biofrontera to Present at the Canaccord Genuity Annual Growth Conference (LON:B8F)
www.pressetext.com - July 25 at 8:31 AM
4-traders.com logoAd-hoc: Biofrontera AG and Maruho Initiate Joint Project to Explore Development Opportunities (LON:B8F)
www.4-traders.com - July 13 at 9:10 PM
4-traders.com logoBiofrontera : Initiates Phase III Trial of Ameluz® in Combination with Daylight-PDT (LON:B8F)
www.4-traders.com - June 30 at 9:08 PM
News IconBiofrontera AG: Biofrontera Progresses with Expansion of U.S. Subsidiary with Key Personnel Hires (LON:B8F)
www.pressetext.com - June 23 at 11:10 PM
4-traders.com logoBiofrontera : Progresses with Expansion of U.S. Subsidiary with Key Personnel Hires (LON:B8F)
www.4-traders.com - June 23 at 11:10 PM
News IconBiofrontera AG: Biofrontera Reports First Quarter 2016 Financial Results and Business Update (LON:B8F)
www.pressetext.com - May 26 at 5:06 PM
publicnow.com logoNotice of quarterly report of 2016 (LON:B8F)
www.publicnow.com - May 23 at 2:36 AM
finance.yahoo.com logoBiofrontera AG: Notice of Annual Results 2016 (LON:B8F)
finance.yahoo.com - April 7 at 8:02 AM
News IconPTA-News: Biofrontera AG: Results of Phase III clinical trial evaluating BF-200 ALAfor treatment of basal cell carcinoma (BCC) (LON:B8F)
www.finanzen.ch - March 5 at 2:52 PM
News IconPTA-PVR : Nexus AG: Release according to Article 26, Section 1 of the WpHG (LON:B8F)
www.onvista.de - February 16 at 2:55 PM
4-traders.com logoBiofrontera : AG: AG resolves on capital increase (LON:B8F)
www.4-traders.com - February 16 at 2:55 PM
thestreet.com logoBiofrontera AG: Biofrontera AG Resolves On Capital Increase (LON:B8F)
www.thestreet.com - February 16 at 2:55 PM
News IconBiofrontera AG: Data from pivotal Phase III studies with BF-200 ALA introduced to US dermtologists (LON:B8F)
www.pressetext.com - February 11 at 2:45 PM
thestreet.com logoBiofrontera AG: Pivotal Phase III Data Demonstrate Significant Efficacy And Excellent Safety For BF-200 ALA Treatment Of Superficial Skin Cancer (LON:B8F)
www.thestreet.com - February 11 at 2:45 PM
News IconPTA-Adhoc: Biofrontera AG: Biofrontera's Ameluz® achieves excellent results in clinical study for basal cell carcinoma (LON:B8F)
www.onvista.de - January 28 at 2:53 PM
trustnet.com logoFDA completes mid-cylce review of Biofrontera's Ameluz (LON:B8F)
www.trustnet.com - January 27 at 2:22 PM
noodls.com logoBiofrontera AG Notice of Third Quarter Results 2015 (LON:B8F)
www.noodls.com - November 12 at 8:06 AM
noodls.com logoBiofrontera AG Notice of First Half Year Results 2015 (LON:B8F)
www.noodls.com - August 7 at 2:06 AM
finance.yahoo.com logoBiofrontera AG: Notice of First Half Year Results 2015 (LON:B8F)
finance.yahoo.com - August 7 at 2:01 AM
noodls.com logoNotice of First Quarter Results 2015 (LON:B8F)
www.noodls.com - May 22 at 10:30 AM
finance.yahoo.com logoBiofrontera AG: Notice of First Quarter Results 2015 (LON:B8F)
finance.yahoo.com - May 22 at 10:19 AM
noodls.com logoNotice of Annual Results 2014 (LON:B8F)
www.noodls.com - March 30 at 2:00 AM

Social


Last Updated on 9/30/2016 by MarketBeat.com Staff